Copper control as an antiangiogenic anticancer therapy: Lessons from treating Wilson's disease

Experimental Biology and Medicine

Volumn 226, Issue 7, 2001, Pages 665-673

  Brewer, George J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Cancer; Copper; Tetrathiomolybdate; Zinc

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; ANTINEOPLASTIC AGENT; CERULOPLASMIN; COPPER; ENDOSTATIN; TETRATHIOMOLYBDIC ACID; ZINC;

ANGIOGENESIS; CANCER GROWTH; CANCER INHIBITION; COPPER METABOLISM; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; GROWTH REGULATION; HUMAN; NONHUMAN; SHORT SURVEY; SIDE EFFECT; WILSON DISEASE;

EID: 0034937998     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222600712     Document Type: Short Survey

References (80)

1. Wilson's Disease
2. Wilson Disease
3. Treatment of Wilson's disease with zinc: XV. Long-term follow-up studies
4. Recognition, diagnosis and management of Wilson's disease
5. Penicillamine: A new oral therapy for Wilson's disease
6. Treatment of Wilson's disease with trientine (triethylene tetramine) dichloride
7. The treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction
8. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy
9. The teart pastures of Somerset. I: The cause and cure of teartness
10. Some preliminary observations of the effect of molybdenum on copper metabolism in herbivorous animals
11. Interrelations of copper, molybdenum and sulfate sulfur in nutrition
12. Thiomolybdates and the copper-molybdenum-sulfur interaction in ruminant nutrition
13. The biochemical pathogenesis of molybdenum-induced copper deficiency syndromes in ruminants: Towards the final chapter
14. A comparison of the effects of penicillamine, trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro: Implications for Wilson's disease therapy
15. Effects of molybdate, sulfide, and tetrathiomolybdate on copper metabolism in rats
16. Treatment of Wilson disease with ammonium lybdate: II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy
17. Treatment of Wilson's disease with ammonium tetrathiomolybdate: I. Initial therapy in 17 neurologically affected patients
18. Initial therapy of patients with Wilson's disease with tetrathiomolybdate
19. Characterization and quantification of copper sulfate-induced vascularization of the rabbit cornea
20. Ceruloplasmin, copper ions, and angiogenesis
21. 1 and copper in angiogenesis
22. Tumor angiogenesis: Therapeutic implications
23. Anti-angiogenesis: New concept for therapy of solid tumors
24. How is blood vessel growth regulated in normal and neoplastic tissue?
25. Angiogenic factors
26. Angiogenesis and breast cancer
27. Angiogenesis in cancer, vascular, rheumatoid, and other diseases
28. Antiangiogenic therapy
29. Angiogenesis and cancer control: From concept to therapeutic trial
30. Factors promoting tumor angiogenesis
31. An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action
32. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
33. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
34. Inhibition of angiogenesis and tumor growth in the brain: Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor
35. Anticopper treatment inhibits pseudopdial protrusion and invasive spread of 9L gliosarcoma cells in the rat brain
36. Copper regulation of ceruloplasmin in copper-deficient rats
37. Copper depletion as an anti-angiogenic strategy in HER2-neu transgenic mice
38. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: I. Phase I study
39. Quantitative and histochemical analysis of Cu, Zn, and Fe in spontaneous and induced primary tumors in rats
40. 64Cu) in tumor-bearing mice and rats
41. Gangliosides, copper ions and angiogenic capacity of adult tissues
42. Localization of tissue copper in mouse mammary tumors
43. The combination of radiotherapy and the angiogenesis inhibitor tetrathiomolybdate (TM) improves the treatment of primary tumors in mice
44. Pathophysiology of tumor angiogenesis and its relevance in renal cell cancer
45. Mechanisms of angiogenesis in the brain
46. Vascular endothelial growth factor: An important angiogenic mediator in bladder cancer
47. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
48. Role of vascular endothelial growth factor in the regulation of angiogenesis
49. Human vascular permeability factor isolation from U937 cells
50. Inactivation of human fibroblast growth factor-1 (FGF-1) activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalyzed oxidation
51. Growth factor release from amylopectin hydrogel based on copper coordination
52. Purified monocyte-derived angiogenic substance (angiotropin) stimulates migration, phenotypic changes, and "tube formation" but not proliferation of capillary endothelial cells in vitro
53. Interaction of human angiogenin with copper modulates angiogenin binding to endothelial cells
54. Copper stimulated proliferation of human endothelial cells
55. SPARC is a source of copper-binding peptides that stimulate angiogenesis
56. Angiogenesis
57. Undetectable intracellular free copper: The requirement of a copper chaperone for superoxide dismutase
58. A delicate balance: Homeostatic control of copper uptake and distribution
59. Metal concentrations in chironomids in relation to peatland geochemistry
60. Mineral composition of pastures in the North and Northwest regions of Rio de Janeiro State. 2, Manganese, iron, zinc, copper, cobalt, molybdenum and lead
61. Copper in Trasbaikal flora
62. The content of different copper compounds in gray forest soils of Mordovia and effectiveness of preplanting treatment of barley seeds with copper sulfate
63. Availability of copper to rice plants, from peat applied to soils to the state of Parana, Brazil
64. Mineral deficiencies and imbalances in cattle and sheep: A review of Brazilian studies made between 1987 and 1998
65. Copper concentrations and cytochromeoxidase and ribonuclease activities in the brains of copper deficient lambs
66. A natural copper deficiency in cattle rations
67. Maternal and lamb breed interactions in the concentration of copper in tissues and plasma of sheep
68. Histopathology of enzootic ataxia in Sika deer (Cervus nippon Temminck)
69. Copper-regulatory domain involved in gene expression
70. The Saccharomyces cerevisiae copper transport protein (Ctr 1 p)
71. Copper-specific transcriptional repression of yeast genes encoding critical components in the copper transport pathway
72. Evidence for the Saccharomyces cerevisiae ferrireductase system being a multicomponent electron transfer chain
73. Evidence for Cu(II) reduction as a component of copper uptake by Saccharomyces cerevisiae
74. Homeostatic regulation of copper uptake in yeast via direct binding of MAC1 protein to upstream regulatory sequences of FRE 1 and CTR 1
75. GRISEA, a putative copper-activated transcription factor from Podospora anserina involved in differentiation and senescence
76. GRISEA, a copper-modulated transcription factor from Podospora anserina involved in senescence and morphogenesis, is an ortholog of MAC1 in Saccharomyces cerevisiae
77. Mitochondrial DNA rearrangements of Podospora anserina are under the control of the nuclear gene grisea
78. The pathogenesis of "falling disease": Studies of copper deficiency in cattle
79. Copper in the environment. Part II. Health effects